Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lonza to Sell Lipogen Phosphatidylserine - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

Lonza to Sell Lipogen Phosphatidylserine

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Bolstering its nutrition ingredient portfolio, Lonza, Basel, Switzerland, has entered a global commercial partnership with Lipogen for the exclusive rights to sell phosphatidylserine (PS) and PS-based formulations in dietary supplements, medical foods and food and beverages under the Lonza name. Lonza intends to roll out launch activities in the U.S. in the fourth quarter of 2011, and expand to other global regions thereafter.

PS, which may reduce the risk of dementia and cognitive dysfunction in the elderly as well as reduce stress and mental fatigue, is the only cognitive health ingredient in the U.S. to receive a qualified health claim from FDA. Lipogen PS also obtained FDA affirmed Generally Recognized As Safe (GRAS) status.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Topics